According to The Fly, researchers at Bank of America published a report on Wednesday announcing that they had begun covering Kimberly-Clark (NYSE: KMB) shares. The company has provided an evaluation of “neutral” for the shares. Other research analysts have recently authored studies on the stock, which have just recently been published. In a research note issued on the 27th of July, UBS Group increased its price objective on Kimberly-Clark shares from $136.00 to $140.00 and gave the firm a “neutral” rating in a research note. The research note was issued in conjunction with the release of the research note. On Friday, July 22nd, StockNews.com reassessed its position on Kimberly-Clark shares, moving them from a “hold” rating to a “buy” recommendation. This move reflects an increase in optimism toward the firm’s future prospects.
Last but not least, in a research report that Barclays released on Monday, May 23rd, the company rated Kimberly-Clark as an “equal weight” business and decreased their target price on Kimberly-Clark shares from $129.00 to $120.00. The firm lowered its target price on Kimberly-Clark shares from $129.00 to $120.00. It has been recommended to purchase the stock by one research analyst, sell it by two research analysts, and hold the stock by eleven research experts. Information from Bloomberg.com indicates that the company has been assigned an average recommendation of “Hold” and that its target price has been determined to be $131.15. On Wednesday morning, the opening price of KMB shares on the New York Stock Exchange was $123.76. The moving average of the company’s stock price over the past 50 days is $132.49, while the moving average over the previous 200 days is $130.52. With a market valuation of $41.78 billion, a PE ratio of 23.40, a PEG ratio of 4.50, and a beta value of 0.31, the company maintains a dominant position in the industry, which is not surprising considering its size. Some current ratios include a quick ratio of 0.47, a current ratio of 0.79, and a debt-to-equity ratio of 10.37. Kimberly-one-year Clark’s lowest price was $117.32, while the stock’s all-time high is $145.78.
Kimberly-Clark (NYSE: KMB) released its most recent quarterly results report on July 26th, which was a Tuesday. The company reported $1.34 per share earnings for the quarter, which was ($0.01) below the general forecast of $1.35 per share in circulation. The company’s revenues came in at $5.06 billion for the quarter, which was much better than the average projection of $4.99 billion in sales. Kimberly-Clark had a return on equity of 249.60%, and the business had a net margin of 8.87% at the end of the fiscal year. Compared to the revenue generated during the same period in the prior year, this quarter’s revenue showed a 7.2% increase. The company reported $1.47 per share earnings for the same quarter in the preceding year’s financial statements. According to the forecasts of equity research analysts, Kimberly-Clark would rake in profits of $5.64 per share during the current financial year.
Recent transactions involving the company’s stock involved several institutional investors purchasing and selling shares. These transactions have taken place in recent times. During the fourth quarter of the fiscal year, Bivin & Associates, Inc. invested in Kimberly-Clark shares worth $26,000. The New Millennium Group LLC invested in Kimberly-Clark during the second quarter, valued at $27,000. Wagner Wealth Management LLC invested in Kimberly-Clark Corporation during the second quarter of the fiscal year, amounting to $28,000. In addition, the amount of money HWG Holdings LP invested in Kimberly-Clark increased by $29,000 over the final three months of 2018. And finally, during the first three months of this year, Roble Belko & Company Inc. boosted the percentage of Kimberly-Clark shares it owned by 69.5%, bringing its total ownership percentage to a total of 1.0%. Roble Belko & Company, Inc. purchased 105 shares of the firm’s stock during the most recent quarter. This brings the total number of shares directly held by the company to 256, with a value of $32,000. The majority of the company’s stock is owned by institutional investors and hedge funds, which account for 74.36% of the company’s total shares.
The Kimberly-Clark Corporation and its subsidiary firms manufacture and distribute consumer tissue products and personal care items worldwide. These responsibilities include both domestic and international markets. It operates under three main business divisions: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care business sells disposable diapers, swimwear, training pants, youth pants, baby wipes, feminine and incontinence care products, and other items under various brand names. These brand names include Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, and Poise. In addition, the personal care business sells